Hormones
Researchers at Wake Forest University have published new data on hormones
Published in Cancer Weekly, December 15th, 2009
In this recent report, researchers in the United States conducted a study "To compare the effects of two selective estrogen receptor modulators, tamoxifen and raloxifene, on global and domain-specific cognitive function. The National Surgical Adjuvant Breast and Bowel Project's Study of Tamoxifen and Raloxifene (STAR) study was a randomized clinical trial of tamoxifen 20 mg/d or raloxifene 60 mg/d in healthy postmenopausal women at increased risk of breast cancer."
"The 1,498 women who were randomly assigned in STAR were age 65 years and older, were not diagnosed with dementia, and were enrolled onto the Cognition in the Study of Tamoxifen and Raloxifene (Co-STAR)...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2009-12-15)
More Articles from Cancer Weekly
- American Association for Cancer Research
Mexican-American youths' risk of experimenting with cigarettes depends on susceptibility - American Association for Cancer Research
Repeat negative CT scan for lung cancer does not encourage ex-smokers to resume the habit - American Gastroenterological Association
New CRC screening combination increases detection by 10 percent - International Association for the Study of Lung Cancer
Study shows modest improvement in advanced lung cancer overall survival rates - Journal of the National Cancer Institute
News brief: Estrogen receptor-alpha, breast cancer patients and tamoxifen response - Massachusetts General Hospital
Videos can help cancer patients choose level of care they prefer - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
